Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000278291 | SCV000332147 | uncertain significance | not provided | 2015-06-23 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000332147 | SCV000366647 | uncertain significance | Jeune thoracic dystrophy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000389075 | SCV000366648 | uncertain significance | Asphyxiating thoracic dystrophy 3 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Invitae | RCV000332147 | SCV000630946 | likely benign | Jeune thoracic dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000278291 | SCV002008460 | uncertain significance | not provided | 2021-10-22 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
ARUP Laboratories, |
RCV000389075 | SCV004562109 | uncertain significance | Asphyxiating thoracic dystrophy 3 | 2023-09-18 | criteria provided, single submitter | clinical testing | The DYNC2H1 c.3170G>A; p.Arg1057His variant (rs191381310), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 281379). This variant is found in the general population with an overall allele frequency of 0.05% (99/189,496 alleles) in the Genome Aggregation Database. Computational analyses predict that this variant is neutral (REVEL: 0.126). Due to limited information, the clinical significance of this variant is uncertain at this time. |
Laboratory of Diagnostic Genome Analysis, |
RCV000278291 | SCV001797646 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000278291 | SCV001968152 | uncertain significance | not provided | no assertion criteria provided | clinical testing |